Edition:
United Kingdom

Pharma Mar SA (PHMR.MC)

PHMR.MC on Madrid SE C.A.T.S.

1.81EUR
24 Jun 2019
Change (% chg)

€-0.07 (-3.72%)
Prev Close
€1.88
Open
€1.85
Day's High
€1.90
Day's Low
€1.80
Volume
1,227,513
Avg. Vol
1,347,741
52-wk High
€2.42
52-wk Low
€0.87

About

Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical... (more)

Overall

Beta: 1.48
Market Cap(Mil.): €418.58
Shares Outstanding(Mil.): 222.65
Dividend: --
Yield (%): --

Financials

  PHMR.MC Industry Sector
P/E (TTM): -- 32.50 37.40
EPS (TTM): -0.11 -- --
ROI: -24.65 12.49 12.12
ROE: -137.02 13.80 17.02

BRIEF-Pharma Mar Says Lurbinectedin Achieves Positive Results In Phase II Trial For Treatment Of Small Cell Lung Cancer

* SAID ON SATURDAY LURBINECTEDIN ACHIEVED PRIMARY ENDPOINT OF OVERALL RESPONSE RATE (ORR) IN PHASE II TRIAL

03 Jun 2019

BRIEF-Pharma Mar To Sell Its Stake in Zelnova Zeltia

* SAID ON MONDAY IT HAD GRANTED A MANDATE TO ALANTRA CORPORATE FINANCE SAU FOR THE SALE OF ITS STAKE IN ITS UNIT ZELNOVA ZELTIA SA

29 Jan 2019

Earnings vs. Estimates